Evidence map›Paper›PMID 25878297›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Infectious disease modeling methods as tools for informing response to novel influenza viruses of unknown pandemic potential.

Manoj Gambhir, Catherine Bozio, Justin J O'Hagan, Amra Uzicanin, Lucinda E Johnson, Matthew Biggerstaff, David L Swerdlow

Abstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Research gaps and priorities for quantitative microbial risk assessment (QMRA).Risk analysis : an official publication of the Society for Risk Analysis · 2024
    Article
  3. Modeling zoonotic and vector-borne viruses.Current opinion in virology · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manoj GambhirEpidemiological Modelling Unit, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia Modeling Unit, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) IHRC Inc.
Catherine BozioGraduate Program in Epidemiology and Molecules to Mankind, Laney Graduate School, Emory University.
Justin J O'HaganModeling Unit, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) IHRC Inc.
Amra UzicaninDivision of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases.
Lucinda E JohnsonInfluenza Division.
Matthew BiggerstaffInfluenza Division.
David L SwerdlowModeling Unit and Office of the Director, NCIRD, CDC, Atlanta, Georgia.

Funding

Models for synthesising molecular, clinical and epidemiological data, and translaU01GM110721 · NIGMS · IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE · PI CAUCHEMEZ, SIMON, FERGUSON, NEIL MORRIS · 2014 to 2018
$1.9M
NIGMS NIH HHS U01 GM110721
6 · The paper itself

Abstract

The rising importance of infectious disease modeling makes this an appropriate time for a guide for public health practitioners tasked with preparing for, and responding to, an influenza pandemic. We list several questions that public health practitioners commonly ask about pandemic influenza and match these with analytical methods, giving details on when during a pandemic the methods can be used, how long it might take to implement them, and what data are required. Although software to perform these tasks is available, care needs to be taken to understand: (1) the type of data needed, (2) the implementation of the methods, and (3) the interpretation of results in terms of model uncertainty and sensitivity. Public health leaders can use this article to evaluate the modeling literature, determine which methods can provide appropriate evidence for decision-making, and to help them request modeling work from in-house teams or academic groups.

Indexed as

Models, TheoreticalPandemicsCommunicable DiseasesDisaster PlanningEpidemiological MonitoringHumansInfluenza, HumanOrthomyxoviridaeUnited States

Identifiers

PMID25878297
PMCPMC4481577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.